Company profile
Akari Therapeutics Plc insider acquisitions
Company CIK 0001541157 · Reported insider acquisitions and filing context.
AKTX · Nasdaq
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | American Depositary Shares representing Ordinary SharesNon-derivative · Currency not specified | 6 | Not applicable | 0 |
| Stock awardCode A | Stock Option (Right to Buy)Derivative · Currency not specified | 1 | Not applicable | 0 |
| Exercise / conversionCode M | American Depositary Shares representing Ordinary SharesNon-derivative · Currency not specified | 6 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition
50 dated transactions · 8 of 8 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Prudo-Chlebosz Raymond | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Prudo-Chlebosz Raymond | Stock award |
| Oct 5, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Prudo-Chlebosz Raymond | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Prudo-Chlebosz Raymond | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Huh Hoyoung | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Huh Hoyoung | Stock award |
| Oct 5, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Huh Hoyoung | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Huh Hoyoung | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Patel Sandip I | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Patel Sandip I | Stock award |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Patel Sandip I | Exercise / conversion |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Patel Sandip I | Exercise / conversion |
| Oct 5, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Patel Sandip I | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Patel Sandip I | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Bazemore Robert B | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Bazemore Robert B | Stock award |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Bazemore Robert B | Exercise / conversion |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Bazemore Robert B | Exercise / conversion |
| Oct 5, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Bazemore Robert B | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Bazemore Robert B | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Gaslightwala Abizer | Stock award |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Gaslightwala Abizer | Exercise / conversion |
| Oct 14, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Gaslightwala Abizer | Exercise / conversion |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Patel Samir Rashmikant | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Patel Samir Rashmikant | Stock award |
| Oct 5, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Patel Samir Rashmikant | Stock award |
| Aug 18, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Patel Samir Rashmikant | Stock award |
| Oct 12, 2026 | Akari Therapeutics PlcStock Option (Right to Buy) | Vat-Ho Vatnak | Stock award |
| Sep 29, 2026 | Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary Shares | Gaslightwala Abizer | Stock award |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Prudo-Chlebosz Raymond | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Prudo-Chlebosz Raymond | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Prudo-Chlebosz Raymond | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Prudo-Chlebosz Raymond | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Sandip I | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Patel Sandip I | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Sandip I | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Patel Sandip I | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Huh Hoyoung | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Huh Hoyoung | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Huh Hoyoung | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Huh Hoyoung | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Farag Kameel D. | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Farag Kameel D. | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Samir Rashmikant | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Patel Samir Rashmikant | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Patel Samir Rashmikant | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs") | Patel Samir Rashmikant | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Gaslightwala Abizer | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcWarrants to purchase ADRs | Gaslightwala Abizer | Purchase |
| Dec 16, 2025 | Akari Therapeutics PlcPre-Funded Warrants to purchase ADRs | Gaslightwala Abizer | Purchase |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
AKTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Prudo-Chlebosz RaymondDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 15,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 30,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 3,240 | 7.899Value: 25,592.76Currency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 9,072 | 7.899Value: 71,659.728Currency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | Stock awardStock Option (Right to Buy)Derivative security · Code A | 15,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | Stock awardStock Option (Right to Buy)Derivative security · Code A | 30,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 6,160 | 7.899Value: 48,657.84Currency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 17,249 | 7.899Value: 136,249.851Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 15,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 45,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 6,186 | 0.0004Value: 2.4744Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 3,866 | 0.0004Value: 1.5464Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 4,313 | 7.899Value: 34,068.387Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 12,100 | 7.899Value: 95,577.9Currency not specified | View ↗ |
| Trade: | Bazemore Robert BDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 15,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Bazemore Robert BDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 45,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Bazemore Robert BDirector | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 3,093 | 0.0004Value: 1.2372Currency not specified | View ↗ |
| Trade: | Bazemore Robert BDirector | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 773 | 0.0004Value: 0.3092Currency not specified | View ↗ |
| Trade: | Bazemore Robert BDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 4,677 | 7.899Value: 36,943.623Currency not specified | View ↗ |
| Trade: | Bazemore Robert BDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 13,100 | 7.899Value: 103,476.9Currency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 174,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 7,733 | 0.0004Value: 3.0932Currency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | Exercise / conversionAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code M | 19,333 | 0.0004Value: 7.7332Currency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 15,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 30,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 2,236 | 7.899Value: 17,662.164Currency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 6,300 | 7.899Value: 49,763.7Currency not specified | View ↗ |
| Trade: | Vat-Ho VatnakChief Business Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 87,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A | 6,430 | 9.72Value: 62,499.6Currency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 386,661 | 0.4041 *Value: 156,249.7101Currency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | PurchaseWarrants to purchase ADRsDerivative security · Code P | 386,661 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 618,658 | 0.4041 *Value: 249,999.6978Currency not specified | View ↗ |
| Trade: | Prudo-Chlebosz RaymondDirector | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 618,658 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 154,664 | 0.4041 *Value: 62,499.7224Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | PurchaseWarrants to purchase ADRsDerivative security · Code P | 154,664 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 247,462 | 0.4041 *Value: 99,999.3942Currency not specified | View ↗ |
| Trade: | Patel Sandip IDirector | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 247,462 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 3,093,293 | 0.4041 *Value: 1,249,999.7013Currency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | PurchaseWarrants to purchase ADRsDerivative security · Code P | 3,093,293 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 618,658 | 0.4041 *Value: 249,999.6978Currency not specified | View ↗ |
| Trade: | Huh HoyoungDirector · 10% owner | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 618,658 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Farag Kameel D.Interim CFO | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 24,745 | 0.4041 *Value: 9,999.4545Currency not specified | View ↗ |
| Trade: | Farag Kameel D.Interim CFO | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 24,745 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 231,997 | 0.4041 *Value: 93,749.9877Currency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector · 10% owner | PurchaseWarrants to purchase ADRsDerivative security · Code P | 231,997 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector · 10% owner | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 618,658 | 0.4041 *Value: 249,999.6978Currency not specified | View ↗ |
| Trade: | Patel Samir RashmikantDirector · 10% owner | PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P | 618,658 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 773,323 | 0.4041 *Value: 312,499.8243Currency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | PurchaseWarrants to purchase ADRsDerivative security · Code P | 773,323 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Gaslightwala AbizerCEO · Director | PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P | 309,328 | 0.4041 *Value: 124,999.4448Currency not specified | View ↗ |
50 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →